C5-substituted pyrido[2,3-d]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR(T790M) mutant
文献类型：期刊论文
| 作者 | Ding, Ke; Ren, Xiaomei; Zhang, Lianwen; Yu, Lei; Luo, Jinfeng; Zhang, Zhang; Xu, Tianfeng; Tu, Zhengchao; Tong, Linjiang; Huang, Zhaoru |
| 刊名 | MEDCHEMCOMM
 |
| 出版日期 | 2015 |
| 卷号 | 6期号:9页码:1693-1697 |
| ISSN号 | 2040-2503 |
| 学科主题 | Biochemistry & Molecular Biology ; Pharmacology & Pharmacy |
| 语种 | 英语 |
| 源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/721]  |
| 专题 | 中国科学院广州生物医药与健康研究院 |
| 推荐引用方式 GB/T 7714 | Ding, Ke,Ren, Xiaomei,Zhang, Lianwen,et al. C5-substituted pyrido[2,3-d]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR(T790M) mutant[J]. MEDCHEMCOMM,2015,6(9):1693-1697. |
| APA | Ding, Ke.,Ren, Xiaomei.,Zhang, Lianwen.,Yu, Lei.,Luo, Jinfeng.,...&Xie, Hua.(2015).C5-substituted pyrido[2,3-d]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR(T790M) mutant.MEDCHEMCOMM,6(9),1693-1697. |
| MLA | Ding, Ke,et al."C5-substituted pyrido[2,3-d]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR(T790M) mutant".MEDCHEMCOMM 6.9(2015):1693-1697. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。